Eczema in Children: When to Consider a Clinical Trial
Pediatric atopic dermatitis is the most common chronic skin disease in children. Here is when a clinical trial might be the right option for your child.
Read Article →Insights, guides, and stories to help you navigate your clinical research journey.
Pediatric atopic dermatitis is the most common chronic skin disease in children. Here is when a clinical trial might be the right option for your child.
Read Article →
The biologic revolution has transformed treatment for moderate-to-severe atopic dermatitis. Here is where the science stands and what is coming next.
Read Article →
South Florida’s hot, humid climate creates unique challenges for eczema patients. Here are dermatologist-recommended tips for managing eczema in the tropics.
Read Article →
The itch-scratch cycle is one of the most frustrating aspects of atopic dermatitis. Here is why it happens and what can break it.
Read Article →
Moderate-to-severe eczema affects nearly every aspect of daily life. Here is practical guidance for managing symptoms, triggers, and mental health impact.
Read Article →
NEMLUVIO (nemolizumab) is an FDA-approved biologic for atopic dermatitis. Here is what patients prescribed NEMLUVIO should know, including an observational study at NuLine.
Read Article →
The EASI score is the standard tool for measuring atopic dermatitis severity in clinical trials. Here is what it measures and why it matters.
Read Article →
Transepidermal water loss (TEWL) is a critical measure of skin barrier function. Here is why it matters for eczema patients and how it is measured.
Read Article →
Atopic dermatitis affects over 31 million Americans. Learn about the latest research and how clinical trials are advancing treatment options.
Read Article →